Qiuning (Frank) Sun

Mr. Sun's recent experience includes advising:

Control Acquisitions

• Loscam on its acquisition of CHEP China, a China-based subsidiary of Brambles and provider of pallet and automotive pooling operations
• MBK Partners on its US$950 million acquisition of ocean parks across China from Hong Kong-listed hospitality group Haichang Ocean Park Holdings Ltd.
• Trustar Capital, formerly CITIC Capital Partners, on the:
  • acquisition of Salion Food Condiment Company Limited, a condiment and seasoning manufacturer with its principal business in China
  • acquisition of Amoy Food Limited and other assets related to the “AMOY” brand sauce and frozen food business from Ajinomoto Co., Inc.
  • acquisition of a 55% stake in China Merchants Loscam International Holdings Co., Limited from HK-listed Sinotrans, together with FountainVest
  • acquisition of Axilone, a France-based manufacturer of premium plastic and metal packaging for global cosmetics brands
  • sale of a controlling stake in King Koil Shanghai Sleep System Co., Ltd., a manufacturer and retailer of premium mattresses in China, to Advent International
• Carlyle Asia Partners on the sale of its controlling stake in Crystal Orange Hotel Holdings, a boutique hotel operator in China
• Sinotrans Limited, the largest integrated logistics service provider in China, in its €385.7 million 100% acquisition of KLG Europe, a leading logistics solutions provider in Europe, in a two-step acquisition
• Vipshop Holdings on its acquisition of Shan Shan Commercial Group, a China-based owner and operator of a chain of outlets

Public M&As

• A buyer consortium led by Mr. Bing Zhang, the chief executive officer and chairman of Glory Star New Media Group Holdings Limited (GSMG), in the proposed going private of GSMG
• Tencent on its US$1.38 billion take-private of Leyou Technologies, an international game development and distribution company, by way of a scheme of arrangement
• CITIC Capital as a major member of the buyer consortium on the US$4.76 billion privatization of US-listed China Biologic Products Holdings Inc., a developer of plasma-based therapies
• The buyer consortium on the US$1.1 billion privatization of Bitauto Holdings Limited, an US-listed internet content and marketing service provider focusing on the automobile industry, and Tencent as a joint offeror on the consequential mandatory general offer for Yixin Group Limited, Bitauto’s Hong Kong-listed subsidiary, as triggered by the Bitauto privatization
• Haier Electronics Group on its proposed acquisition of a controlling stake in Ozner Water International Holding Limited, a China-based water and air purification company listed in Hong Kong

PIPEs

• Binance, one of the world’s largest cryptocurrency and blockchain infrastructure providers, on its US$200 million strategic investment in Forbes, the iconic US business information brand
• CPPIB on its investment in Hutchison China MediTech Limited, an innovative biopharmaceutical company in China dual listed on the London Stock Exchange’s AIM market and on the Nasdaq Global Select Market
• The Carlyle Group on its acquisition through its fund, CAP V Mauritius, of a 5% stake in Shenzhen Salubris Pharmaceuticals, an A-share listed biopharmaceutical company
• Tencent on the subscription of US$100 million convertible notes issued by US-listed NIO Inc., a pioneer in China’s premium electric vehicle market, through a private placement
• L Catterton Asia on its investment with JD.com in NASDAQ-listed Secoo Holding Limited, Asia’s largest online integrated upscale products and services platform, through a subscription of convertible note and warrant
• Vipshop Holdings Limited, a leading online discount retailer for brands in China, in its approximately US$863 million issuance of Class A ordinary shares to, and concurrent business cooperation arrangements with, Tencent and JD.com
• Orix Asia Capital on the subscription of new shares and warrants issued by Hong Kong-listed United Photovoltaics Group Limited, which is sought to raise equity and debt financing to redeem a certain portion of its outstanding convertible bonds
• China Traditional Chinese Medicine Holdings Co. Limited on placing 604.3 million shares to Ping An Life Insurance Company of China for HK$2.68 billion

Growth Capital

• Primavera on:
  • Series B financing of Zoox, a leading US autonomous-driving startup based in Silicon Valley
  • Series C financing of LoveBonito, Singapore's leading fashion online store for women's wear
  • Series E financing of Bytedance, a Chinese internet technology company
  • Series B financing of Hex Trust, digital asset custody platform
  • Series A financing for a Chinese biomedical company
• Boyu Capital on the Series D financing of Klook, Asia’s largest in-destination services booking platform
• ORIX Asia Capital on:
  • Series D financing of Dianrong, a China-based online platform for borrowing and lending money
  • Investing in WeCash, a China-based online credit evaluation platform
• The Carlyle Group on the Series D financing of Abbisko Therapeutics, a clinical-stage biopharmaceutical company
• A leading state owned investment firm on:
  • Series C financing of a cryptocurrency-trading platform
  • An investment into a Hong Kong-based gamification and blockchain leader
  • Series A-3 financing of an AI company based in China
  • An equity and token investment into a China-based GameFi/AI platform
• Goldman Sachs and a Chinese private equity investment firm on their minority investment in Arrail Group Limited, a leading private dental service provider in China
• Beijing Kuaishou Technology Co., Ltd, a technology company that develops content sharing platforms, on the Series F financing
• Agricultural Bank of China International in its minority investment in Baidu Financing, the financing business carved out from Baidu.com
• An international PE investor on the Series C investment in Ant International, an innovative technology provider